Observational Study of Ketamine Infusions for the Treatment of Chronic Pain
Enrolling by invitationNCT05477004
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This observational study will collect prospectively specified data on patient characteristics and clinically relevant outcomes in patients who receive a ketamine infusion at Stanford Pain Management Center for the treatment of chronic pain, with the goal of identifying treatment responders and relationships between patient characteristics and treatment response.
Study details
- Official title
- Ketamine Infusion for the Treatment Chronic Pain in Adults: a Prospective Observational Study to Characterize Predictors and Outcomes
- Conditions
- Interventions
- Sponsor
- Theresa Lii
- Organization
- Stanford University
- Start date
- 2022-06-01
- Primary completion
- 2026-12-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Has been seen at Stanford's Pain Management Center for a doctor's visit at least once. * Is scheduled to undergo at least 1 ketamine infusion for the treatment of any chronic pain condition. * Have a valid email address and consents to receiving surveys by email. * Able to read, understand, and respond to English-language surveys on an electronic device such as a cell phone, tablet, or computer. * Able to read, understand, and provide written, dated informed consent. Exclusion Criteria: * Has their ketamine infusion cancelled, which may occur before or after consenting to this study.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05477004